Glabella Botox in Irvine, CA — Frown Lines & the 11s

The glabellar complex involves three muscles working together to pull the brows inward and downward. The corrugator supercilii is the primary frown muscle, drawing each brow medially toward the midline. The procerus pulls the skin of the nasal bridge upward and creates a horizontal crease at the nose root. The depressor supercilii contributes to the downward pull at the medial brow.

Repeated contraction of this complex over years creates the vertical 11 lines between the eyebrows that patients commonly seek to soften. Glabella Botox typically targets all three muscles — missing the procerus leaves residual horizontal nose-root creasing, and missing the corrugator leaves a residual frown.

Glabella Botox is injected with a fine needle into the muscle belly of each of the five Carruthers points. Dr. Sabeen Munib, MD palpates the corrugator at rest and on a controlled frown to confirm muscle position before each injection, because the levator palpebrae — the muscle that lifts the upper eyelid — lies just deep to the corrugator near the supraorbital foramen. Injections at the lateral corrugator are placed superficially and medial to the supraorbital nerve to keep product away from the levator.

Depth matters as much as placement. The corrugator sits between the dermis and the bone of the supraorbital ridge; an injection too deep risks diffusion to the levator, while one too superficial can produce a small visible bleb without reaching the muscle. The procerus point at the central glabella is placed into the muscle just at the bridge of the nose — not too superior, where it would catch the medial corrugator, and not too deep, where it would migrate downward. Most treatments take about ten minutes from skin marking to last injection, with no incisions and minimal downtime.

Eyelid ptosis — a temporary droop of the upper eyelid — is the most-discussed risk specific to glabella Botox. It happens when product diffuses through the supraorbital foramen and reaches the levator palpebrae superioris muscle. Across large clinical trials of onabotulinumtoxinA for glabellar lines, ptosis is reported in a low single-digit share of treatments and is dose- and technique-dependent. The droop typically begins between days seven and fourteen, when the toxin reaches peak effect, and it is more common with higher doses or with injection points placed too close to the supraorbital notch.

Dr. Sabeen Munib, MD reduces this risk by injecting the lateral corrugator superficially and staying lateral to the supraorbital notch, by using conservative first-treatment doses, and by asking patients to avoid rubbing the area or lying face down for four hours after injection. The dose at the central procerus point is also kept conservative, since procerus injections placed too deep can let product migrate down to the orbital septum.

When ptosis does occur, it typically resolves on its own over four to six weeks as the toxin's effect wears off. In the interim, apraclonidine eye drops (an alpha-adrenergic agonist) can temporarily lift the upper lid by a millimetre or two by stimulating Müller's muscle, which is enough to make the asymmetry less visible while the body recovers. Dr. Munib will explain this management plan at consultation, not just at the time it happens. Reviewed by Dr. Sabeen Munib, MD on May 25, 2026.

The glabella is usually treated together with the forehead, not alone. The reason is mechanical: the frontalis muscle (which lifts the brow) constantly opposes the glabellar complex (which pulls the brow down). When only the glabellar depressors are relaxed, the frontalis may recruit harder to compensate, deepening horizontal forehead lines or creating an unusually high arched-brow look. Conversely, treating only the forehead without the glabella can let the frown muscles drop the brow. Dr. Sabeen Munib, MD generally plans glabella and forehead Botox as a pair, with the glabella dose set first and the frontalis balanced against it; isolated glabella treatment is appropriate in selected patients with weak frontalis activity or specific brow-shape goals.

When both areas are treated together, the typical pattern is roughly twenty units to the glabella plus another ten to twenty units across the frontalis, depending on forehead height and brow position. Patients with strong frown pull but weaker frontalis activity may need more glabella and less frontalis; patients who compensate heavily with their forehead may need more frontalis to keep the brow position symmetric. This is the kind of judgment that benefits from being treated by the same injector visit after visit — patterns become visible over time.

Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), and Jeuveau (prabotulinumtoxinA) are all botulinum toxin type A products approved for glabellar lines. They differ in unit-to-unit potency (Dysport is roughly 2.5-3 units per 1 Botox unit), in onset (Dysport often kicks in slightly faster), and in formulation (Xeomin has no complexing proteins, which may matter for the small group of patients who develop neutralizing antibodies). For the glabella, the choice is usually one of injector preference and patient history. Read the Dysport vs Botox guide for a deeper comparison.

Glabella Botox results build over the first two weeks as the corrugator, procerus, and depressor supercilii muscles progressively relax. Most patients notice flattening of dynamic 11 lines within three to seven days; the full effect is typically visible by day fourteen. The transition is gradual, not all at once — there is no single moment where the treatment 'kicks in.'

Results generally last three to four months before the muscles gradually recover function, though longevity varies with muscle strength, dose, and whether you also treat the forehead. Patients who maintain consistent glabella Botox over years often find they need slightly less product each session as the corrugator atrophies from disuse — this is normal and not a sign of resistance. A small minority of patients develop neutralizing antibodies to a specific toxin after many treatments; switching to a formulation without complexing proteins (Xeomin) is one option in that situation, and Dr. Munib will discuss it if longevity drops unexpectedly.

A typical maintenance cadence is every three to four months. Patients with stronger frown pull or who exercise heavily (which can metabolise toxin faster) may need treatment slightly more often. Spacing visits too close together does not improve the outcome and can increase the chance of antibody formation, so Dr. Munib generally recommends waiting until movement begins to return rather than topping up early.

Related treatments at Spectrum Skin Clinic in Irvine: Forehead Botox softens horizontal forehead lines and is almost always balanced with the glabella. Botox Brow Lift relaxes brow depressors for subtle medial brow elevation. Bunny Lines Botox addresses nasalis movement on the nose, often balanced with frown-line treatment. Crow's Feet Botox softens periorbital lines at the outer eye. Masseter Botox slims the jawline and is often part of a full-face plan. Chin (mentalis) Botox softens chin dimpling. DAO Botox softens a downturned mouth. Lip Flip with Botox gives a subtle outward roll to the upper lip. Botox in Irvine is our cluster pillar with all upper- and lower-face Botox treatments.

Want to soften the 11 lines between your brows? Book a consultation with Dr. Sabeen Munib, MD at Spectrum Skin Clinic in Irvine. We will assess your frown pattern in animation, set a realistic expectation for dynamic vs static lines, and plan the glabella alongside the forehead where it makes sense.